Virax Biolabs Group's other current assets is $260K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Virax Biolabs Group (VRAX) currently reports a other current assets of $260K as of March 2026. That compares with $540K in the prior-year period — down 51.4% year over year. Use the charts on this page to explore Virax Biolabs Group's other current assets history and peer comparisons.
Virax Biolabs Group's other current assets decreased from $540K to $260K — a 51.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Virax Biolabs Group reported $260K in other current assets as of March 2026. That compares with $540K in the prior-year period — down 51.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $260K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Virax Biolabs Group, and consider following VRAX for alerts when major investors trade the stock.